跳至主要内容
临床试验/ISRCTN56052618
ISRCTN56052618已完成未知

A randomised trial of chlorambucil versus fludarabine as initial therapy of Waldenstrom's macroglobulinaemia and splenic lymphoma with villous lymphocytes

Taunton and Somerset NHS Foundation Trust (UK)0 个研究点目标入组 400 人开始时间: 2004年3月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
400

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • All patients with previously untreated disease who require therapy as judged by their primary physician and who satisfy the eligibilty criteria.

排除标准

  • Not provided at time of registration

研究者

发起方
Taunton and Somerset NHS Foundation Trust (UK)

相似试验